語系:
繁體中文
English
日文
簡体中文
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Lung cancer and personalized medicin...
~
Ahmad, Aamir.
Lung cancer and personalized medicine[electronic resource] :novel therapies and clinical management /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
杜威分類號:
616.9942406
書名/作者:
Lung cancer and personalized medicine : novel therapies and clinical management // edited by Aamir Ahmad, Shirish M. Gadgeel.
其他作者:
Ahmad, Aamir.
出版者:
Cham : : Springer International Publishing :, 2016.
面頁冊數:
x, 231 p. : : ill., digital ;; 24 cm.
Contained By:
Springer eBooks
標題:
Lungs - Cancer
標題:
Biomedicine.
標題:
Cancer Research.
ISBN:
9783319249322
ISBN:
9783319249315
摘要、提要註:
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality.
電子資源:
http://dx.doi.org/10.1007/978-3-319-24932-2
Lung cancer and personalized medicine[electronic resource] :novel therapies and clinical management /
Lung cancer and personalized medicine
novel therapies and clinical management /[electronic resource] :edited by Aamir Ahmad, Shirish M. Gadgeel. - Cham :Springer International Publishing :2016. - x, 231 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.8900065-2598 ;. - Advances in experimental medicine and biology ;946..
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality.
ISBN: 9783319249322
Standard No.: 10.1007/978-3-319-24932-2doiSubjects--Topical Terms:
447997
Lungs
--Cancer
LC Class. No.: RC280.L8
Dewey Class. No.: 616.9942406
Lung cancer and personalized medicine[electronic resource] :novel therapies and clinical management /
LDR
:01888nam a2200313 a 4500
001
455475
003
DE-He213
005
20160803145043.0
006
m d
007
cr nn 008maaau
008
161227s2016 gw s 0 eng d
020
$a
9783319249322
$q
(electronic bk.)
020
$a
9783319249315
$q
(paper)
024
7
$a
10.1007/978-3-319-24932-2
$2
doi
035
$a
978-3-319-24932-2
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC280.L8
072
7
$a
MJCL
$2
bicssc
072
7
$a
MED062000
$2
bisacsh
082
0 4
$a
616.9942406
$2
23
090
$a
RC280.L8
$b
L963 2016
245
0 0
$a
Lung cancer and personalized medicine
$h
[electronic resource] :
$b
novel therapies and clinical management /
$c
edited by Aamir Ahmad, Shirish M. Gadgeel.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2016.
300
$a
x, 231 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Advances in experimental medicine and biology,
$x
0065-2598 ;
$v
v.890
520
$a
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality.
650
0
$a
Lungs
$x
Cancer
$x
Treatment.
$3
447997
650
1 4
$a
Biomedicine.
$3
463454
650
2 4
$a
Cancer Research.
$3
463530
700
1
$a
Ahmad, Aamir.
$3
652251
700
1
$a
Gadgeel, Shirish M.
$3
653888
710
2
$a
SpringerLink (Online service)
$3
463450
773
0
$t
Springer eBooks
830
0
$a
Advances in experimental medicine and biology ;
$v
946.
$3
463635
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-24932-2
950
$a
Biomedical and Life Sciences (Springer-11642)
筆 0 讀者評論
多媒體
多媒體檔案
http://dx.doi.org/10.1007/978-3-319-24932-2
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入